TB-500 is a synthetic peptide related to thymosin β4 (Tβ4) that laboratories use as a reagent to study cell migration and tissue repair. Below we cover what the molecule is, what it does inside the cell, which models it has been studied in, and where the line runs between a preclinical observation and a clinical claim. This material is research use only (RUO) and is not medical advice.
What TB-500 and thymosin β4 are
Thymosin β4 is a natural 43-amino-acid peptide found in almost every animal cell. On the research market the name "TB-500" usually denotes synthetic Tβ4 or its active fragment. That distinction matters: a label reading TB-500 does not by itself prove that a vial holds full-length Tβ4, so the identity of each sample is established from the specification and the analytical report, not from the name on the label.
How thymosin β4 works in the cell
The main known function of Tβ4 is binding monomeric G-actin. The peptide keeps actin in a soluble form and regulates how quickly a cell assembles and disassembles its cytoskeleton. That governs how a cell moves, changes shape, and closes a defect in a tissue layer. A 2005 review describes Tβ4 as an actin-sequestering protein involved in repairing injured tissues [1]. This mechanism explains why the molecule is studied in the context of healing rather than as a hormone or an energy source.
What was actually studied
Experimental data on Tβ4 come from different tissues, and each model answers its own narrow question. A 2002 study examined thymosin β4 in a corneal wound-healing model after alkali injury in vivo, where it sped up closure of the defect and reduced inflammation [2]. A 2012 paper described the mobilization of mesothelial cells in the context of blood-vessel repair [3]. That is cornea and vascular biology, separate biological contexts that do not merge into a single universal result.
| Question to ask of a paper | Why it matters |
|---|---|
| Which form of Tβ4 was studied | To match the paper to a specific sample |
| Which tissue and model | To avoid transferring the result to another context |
| Which control and endpoint | To understand what was actually measured |
Where the evidence ends
All of these observations come from animal and cell systems. There is no approved protocol for use in humans, and no regulator has approved TB-500 as a medicine. Data on the cornea or a vessel are not direct evidence for a joint, a tendon, or a muscle. A correct conclusion names the model and stays within it, and an in vivo result does not carry over automatically either to a human or to an arbitrary vial without a COA for that same batch.
Handling the lyophilizate
For a reproducible experiment the material matters as much as the protocol. A lyophilized peptide is kept sealed and cold, protected from moisture and repeated warming cycles, and a reconstituted solution has a limited shelf life. General reconstitution parameters compiled from open sources are given in the reconstitution reference; these are reference ranges for laboratory work, not instructions for use.
Purity and COA: why it shapes the data
Impurities, a degraded peptide, or a mismatch with the stated form distort the result before the experiment even begins. That is why every unit carries a batch number, and batches come with a certificate of analysis (COA) from an independent third-party laboratory. We do not call these laboratories accredited, because that would be untrue: what matters is the independence of the analysis. We publish the reports in an open archive, so the purity of a specific lot can be checked directly: COA archive. Within the COA itself it is worth separating the identity test, HPLC purity, and quantitative mass content, because a high purity percentage does not establish the identity of the molecule.
If you were looking for the combination with BPC-157
BPC-157 is a separate molecule of gastric origin, and it does not work through actin. The rationale for using them together and the limits of the evidence are covered in a separate article: what research on the BPC-157 + TB-500 blend shows. If you need a single molecule, see TB-500; the combination is available as BPC-157 + TB-500.
Summary
TB-500 (thymosin β4) is a well-characterized actin-sequestering peptide with a long research history in healing models. For a correct experiment the key is to work with material of known purity and to read a COA by its separate parameters. The full source list with chemistry and structure is gathered in the TB-500 monograph.
References
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005. doi:10.1016/j.molmed.2005.07.004
- Sosne G, Szliter EA, Barrett R, et al. Thymosin Beta 4 Promotes Corneal Wound Healing and Decreases Inflammation In Vivo Following Alkali Injury. Experimental Eye Research. 2002. doi:10.1006/exer.2001.1125
- Shelton EL, Bader DM. Thymosin β4 mobilizes mesothelial cells for blood vessel repair. Annals of the New York Academy of Sciences. 2012. doi:10.1111/j.1749-6632.2012.06713.x
Research material. Not a medicine. Not medical advice.
